KIDNEYINTELX

We've invented a new model, which uses our KidneyIntelX™ technology, and focuses on preemptive, precision-based kidney care in the early stages of disease, when it can have the most impact. Our goal: healthier kidneys and happier patients for the long-term... In the future, we'll continue our focus on kidney disease and its comorbidities by expanding our test platform to include screening, diagnosis, next generation prognostic tools, and the monitoring of efficacy and prediction of response to existing and novel therapeutics... Our products - KidneyIntelX and kidneyintelX.dkd - accurately assess the level of individual risk each patient with type 2 diabetes and early stage chronic kidney disease has for progressive decline in kidney function, beyond what occurs during the normal ageing process.

Primary location: London United Kingdom